III 

109TH CONGRESS 

2D SESSION S. RES. 236 

Recognizing the need to pursue research into the causes, a treatment, and 

an eventual cure for idiopathic pulmonary fibrosis, supporting the goals 

and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, 

and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 13, 2005 

Mr. COLEMAN (for himself, Mr. LUGER, Mr. BINGAMAN, Mr. CHAMBLISS, Mr. 

ISAKSON, Mr. BAYH, Mr. BURR, Mr. DURBIN, Ms. SNOWE, Mrs. 

HUTCHISON, and Mr. GRAHAM) submitted the following resolution; which 

was referred to the Committee on Health, Education, Labor, and Pensions 

MAY 25, 2006 

Committee discharged; considered and agreed to 

RESOLUTION 

Recognizing the need to pursue research into the causes, 

a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, 

and for other purposes. 

Whereas idiopathic pulmonary fibrosis is a serious lung disorder causing progressive, incurable lung scarring; 

Whereas idiopathic pulmonary fibrosis is one of about 200 

disorders called interstitial lung diseases; 


jlentini on PROD1PC65 with BILLS
2 

SRES 236 ATS

Whereas idiopathic pulmonary fibrosis is the most common 

form of interstitial lung disease; 

Whereas idiopathic pulmonary fibrosis is a debilitating and 

generally fatal disease marked by progressive scarring of 

the lungs, causing an irreversible loss of the lung tissue’s 

ability to transport oxygen; 

Whereas idiopathic pulmonary fibrosis progresses quickly, 

often causing disability or death within a few short years; 

Whereas there is no proven cause of idiopathic pulmonary fibrosis; 

Whereas approximately 83,000 United States citizens have 

idiopathic pulmonary fibrosis, and 31,000 new cases are 

diagnosed each year; 

Whereas idiopathic pulmonary fibrosis is often misdiagnosed 

or under diagnosed; 

Whereas the median survival rate for idiopathic pulmonary fibrosis patients is 2 to 3 years, and about two thirds of 

idiopathic pulmonary fibrosis patients die within 5 years; 

and 

Whereas a need has been identified to increase awareness and 

detection of this misdiagnosed and under diagnosed disorder: Now, therefore, be it 

1 Resolved, That Congress— 

2 (1) recognizes the need to pursue research into 

3 the causes, a treatment, and an eventual cure for id4 iopathic pulmonary fibrosis; 

5 (2) supports the work of the Coalition for Pul6 monary Fibrosis and its partner organizations for 

7 their great efforts to educate, support, and provide 


jlentini on PROD1PC65 with BILLS
3 

SRES 236 ATS

1 hope for individuals who suffer from idiopathic pul2 monary fibrosis, including the work of the Coalition 

3 to organize a national ‘‘Idiopathic Pulmonary Fibro4 sis Awareness Week’’; 

5 (3) supports the designation of an appropriate 

6 week as ‘‘Idiopathic Pulmonary Fibrosis Awareness 

7 Week’’; 

8 (4) congratulates the Coalition for Pulmonary 

9 Fibrosis for its efforts to educate the public about 

10 idiopathic pulmonary fibrosis, while funding research 

11 to help find a cure for this disorder; and 

12 (5) supports the goals and ideals of a national 

13 ‘‘Idiopathic Pulmonary Fibrosis Awareness Week’’. 

Æ 


jlentini on PROD1PC65 with BILLS